Piramal Pharma
Company Overview - January 14, 2025
Piramal Pharma is a notable player in the Pharmaceuticals - Indian - Bulk Drugs & Formln industry, listed on both the BSE (Code: 543635) and NSE (Code: PPLPHARMA). As of the January 14, 2025, the company holds a market capitalization of INR 35198.58 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 265.50, Piramal Pharma has demonstrated a 93.88% return over the last year. Recent performance indicates fluctuations, with a -1.88% change in the past week and a -2.79% change over the last month. The company's all-time high stands at INR 307.90, while its lowest-ever price was INR 61.62.
In terms of sales, Piramal Pharma reported a revenue of INR 8703.82 crores, solidifying its position in the market. The average trading volume over the past month has been 14326418 shares, with a more recent weekly average of 3037995.
With the stock trading above its 50-day moving average of INR 240.78, the company's technical indicators like MACD (1.16) signal negative trends.
Company Data
Name | Piramal Pharma |
---|---|
BSE Code | 543635 |
NSE Code | PPLPHARMA |
Industry | Pharmaceuticals - Indian - Bulk Drugs & Formln |
Current Price | 265.50 |
Market Capitalization | 35198.58 |
Sales | 8703.82 |
Return over 3months | 29.88 |
Return over 6months | 65.79 |
Volume 1month average | 14326418 |
Volume 1week average | 3037995 |
Volume | 2904645 |
High price | 307.90 |
Low price | 114.35 |
High price all time | 307.90 |
Low price all time | 61.62 |
Return over 1day | 8.10 |
Return over 1week | -1.88 |
Return over 1month | -2.79 |
Return over 1year | 93.88 |
Return over 3years | |
Return over 5years | |
Volume 1year average | 7732216 |
DMA 50 | 240.78 |
DMA 200 | 189.48 |
DMA 50 previous day | 240.59 |
DMA 200 previous day | 188.92 |
MACD | 1.16 |
MACD Signal | 4.82 |